FDA backs Pfizer Covid-19 boosters for seniors, people at high risk

The ruling represents a drastically scaled back version of the Biden administration's sweeping plan to give third doses to nearly all American adults

Comments

Popular posts from this blog

BJP’s victory in local body polls indicator of coming Assembly polls: Bommai

Should there be a lesson on Jinnah?: Karnataka K.S. Eshwarappa asks

Bengaluru: Bus conductor fails to return Rs 1; court orders BMTC to pay Rs 3K as compensation